Breaking News Instant updates and real-time market news.

NVCR

Novocure

$20.08

-0.325 (-1.59%)

04:55
07/31/17
07/31
04:55
07/31/17
04:55

Novocure management to meet with JMP Securities

Meeting to be held in New York on July 31 hosted by JMP Securities.

  • 31

    Jul

  • 15

    Aug

NVCR Novocure
$20.08

-0.325 (-1.59%)

04/06/17
WEDB
04/06/17
NO CHANGE
Target $20
WEDB
Outperform
Wedbush has more confidence in Novocure after meetings, data
After hosting meetings with Novocure management and reviewing presentations at the American Association of Cancer Research conference, Wedbush analyst Tao Levy said he has greater confidence that its Optune System is one of the more exciting, but underappreciated, technology platforms in the space. He keeps an Outperform rating and $20 price target on Novocure shares, which are also on the Wedbush Best Ideas List.
05/24/17
WELS
05/24/17
UPGRADE
Target $15
WELS
Outperform
Novocure upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Larry Biegelsen upgraded Novocure to Outperform and raised his price target for the shares to $15 from $11.50. Feedback from consultants suggest that physician impression of Optune may be improving, Biegelsen tells investors in a research note. The consultants believe that the 5-year safety/efficacy results from EF-14 trial, which showed continued survival benefit, is "meaningful and would be hard to ignore," even for doctors previously skeptical of Optune for treating glioblastoma, the analyst adds.
07/12/17
WEDB
07/12/17
NO CHANGE
WEDB
Novocure removed from Best Ideas List at Wedbush
Wedbush removed Novocure from its Best Ideas List based on valuation.
07/28/17
WEDB
07/28/17
NO CHANGE
WEDB
Outperform
Novocure should be bought on post-earnings pullback, says Wedbush
Wedbush analyst Tao Levy attributes the post-earnings pullback in Novocure to confusion regarding the comparison of the company's reported revenue to the published consensus estimate, but he does not believe it is an "apples-to-apples" comparison. Levy, who said that Optune prescriptions and active patients are "significantly" ahead of expectations, recommends buying the stock on the confusion and keeps an Outperform rating on the shares, which are down 1% in early trading.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,168.92

6.92 (0.60%)

05:24
12/12/17
12/12
05:24
12/12/17
05:24
Hot Stocks
AWS, NWCD announce second AWS region in China now available to customers »

Amazon Web Services, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

SAIL

SailPoint Technologies

$14.83

-0.61 (-3.95%)

05:23
12/12/17
12/12
05:23
12/12/17
05:23
Initiation
SailPoint Technologies initiated  »

SailPoint Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTY

Getty Realty

$28.10

0.08 (0.29%)

05:22
12/12/17
12/12
05:22
12/12/17
05:22
Initiation
Getty Realty initiated  »

Getty Realty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.14

0.84 (3.77%)

05:16
12/12/17
12/12
05:16
12/12/17
05:16
Recommendations
Mallinckrodt analyst commentary  »

Mallinckrodt management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

SFIX

Stitch Fix

$23.98

0.38 (1.61%)

05:13
12/12/17
12/12
05:13
12/12/17
05:13
Initiation
Stitch Fix initiated  »

Stitch Fix initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

WEB

Web.com

$23.00

1.2 (5.50%)

05:10
12/12/17
12/12
05:10
12/12/17
05:10
Downgrade
Web.com rating change  »

Web.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNPS

Synopsys

$89.56

-0.95 (-1.05%)

05:09
12/12/17
12/12
05:09
12/12/17
05:09
Downgrade
Synopsys rating change  »

Synopsys downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNC

SS&C

$41.38

0.75 (1.85%)

05:09
12/12/17
12/12
05:09
12/12/17
05:09
Downgrade
SS&C rating change  »

SS&C downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOW

ServiceNow

$123.09

1.28 (1.05%)

05:08
12/12/17
12/12
05:08
12/12/17
05:08
Downgrade
ServiceNow rating change  »

ServiceNow downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RNG

RingCentral

$47.55

-0.75 (-1.55%)

05:08
12/12/17
12/12
05:08
12/12/17
05:08
Downgrade
RingCentral rating change  »

RingCentral downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTWO

Q2 Holdings

$40.35

-0.1 (-0.25%)

05:07
12/12/17
12/12
05:07
12/12/17
05:07
Downgrade
Q2 Holdings rating change  »

Q2 Holdings downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

QLYS

Qualys

$59.00

0.55 (0.94%)

05:07
12/12/17
12/12
05:07
12/12/17
05:07
Downgrade
Qualys rating change  »

Qualys downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$61.44

-0.26 (-0.42%)

05:06
12/12/17
12/12
05:06
12/12/17
05:06
Downgrade
PTC rating change  »

PTC downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEWR

New Relic

$60.00

2.77 (4.84%)

05:06
12/12/17
12/12
05:06
12/12/17
05:06
Downgrade
New Relic rating change  »

New Relic downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

TYPE

Monotype Imaging

$24.40

-0.2 (-0.81%)

05:05
12/12/17
12/12
05:05
12/12/17
05:05
Downgrade
Monotype Imaging rating change  »

Monotype Imaging…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MODN

Model N

$16.00

0.05 (0.31%)

05:05
12/12/17
12/12
05:05
12/12/17
05:05
Downgrade
Model N rating change  »

Model N downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIME

Mimecast

$28.02

-0.72 (-2.51%)

05:04
12/12/17
12/12
05:04
12/12/17
05:04
Downgrade
Mimecast rating change  »

Mimecast downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMPV

Imperva

$41.85

0.3 (0.72%)

05:04
12/12/17
12/12
05:04
12/12/17
05:04
Downgrade
Imperva rating change  »

Imperva downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDDY

GoDaddy

$48.95

0.07 (0.14%)

05:03
12/12/17
12/12
05:03
12/12/17
05:03
Downgrade
GoDaddy rating change  »

GoDaddy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNT

Fortinet

$42.22

0.27 (0.64%)

05:02
12/12/17
12/12
05:02
12/12/17
05:02
Downgrade
Fortinet rating change  »

Fortinet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 17

    Jan

CSGP

CoStar Group

$290.50

-1.84 (-0.63%)

05:02
12/12/17
12/12
05:02
12/12/17
05:02
Downgrade
CoStar Group rating change  »

CoStar Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 15

    Dec

  • 26

    Feb

CHKP

Check Point

$105.85

1.07 (1.02%)

05:01
12/12/17
12/12
05:01
12/12/17
05:01
Downgrade
Check Point rating change  »

Check Point downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

CUDA

Barracuda

$27.61

0.08 (0.29%)

05:00
12/12/17
12/12
05:00
12/12/17
05:00
Downgrade
Barracuda rating change  »

Barracuda downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$174.31

0.74 (0.43%)

04:59
12/12/17
12/12
04:59
12/12/17
04:59
Downgrade
Adobe rating change  »

Adobe downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

SAIL

SailPoint Technologies

$14.83

-0.61 (-3.95%)

04:56
12/12/17
12/12
04:56
12/12/17
04:56
Initiation
SailPoint Technologies initiated  »

SailPoint Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.